Lakefront Biotherapeutics (GLPGF) Sales of Property, Plant and Equipment (2015 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Sales of Property, Plant and Equipment (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.21 Bn | 197.22 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.48 Bn | 178.31 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.46 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.80 Bn | 74.80 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.62 Bn | 56.43 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.72 Bn | 49.58 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.30 Bn | 30.02 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.28 Bn | 30.28 Bn | 1.16 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 449,320.80 |
| Sep 30, 2025 | 26.68 Mn |
| Dec 31, 2023 | 131,264.67 |
| Dec 31, 2022 | 20,404.95 |
| Dec 31, 2019 | -1,106.89 |
| Sep 30, 2019 | -1,112.73 |
| Jun 30, 2019 | 1,123.64 |
| Mar 31, 2019 | 1,136.63 |
| Dec 31, 2018 | -1,141.40 |
| Mar 31, 2018 | 1,228.53 |
| Dec 31, 2017 | 1,177.43 |
| Jun 30, 2017 | 13.19 Mn |
| Mar 31, 2017 | 1,065.41 |
| Dec 31, 2016 | -15,116.14 |
| Mar 31, 2016 | 17,648.20 |
| Dec 31, 2015 | -67,959.27 |